266 related articles for article (PubMed ID: 10092158)
1. COX-1, COX-2: so what?
Emery P
Scand J Rheumatol; 1999; 28(1):6-9. PubMed ID: 10092158
[TBL] [Abstract][Full Text] [Related]
2. Controversies in COX-2 inhibitor therapy: closing remarks.
Abramson SB; Furst DE; Hochberg MC; Patrono C
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S77-80. PubMed ID: 11695257
[No Abstract] [Full Text] [Related]
3. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
4. Defining COX-2 inhibitors.
Lipsky PE
J Rheumatol Suppl; 2000 Oct; 60():13-6. PubMed ID: 11032097
[TBL] [Abstract][Full Text] [Related]
5. COX-1-sparing NSAIDs--is the enthusiasm justified?
Peterson WL; Cryer B
JAMA; 1999 Nov; 282(20):1961-3. PubMed ID: 10580464
[No Abstract] [Full Text] [Related]
6. Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs.
Daoud KF; Jackson CG; Williams HJ
Compr Ther; 1999; 25(8-10):427-33. PubMed ID: 10520445
[TBL] [Abstract][Full Text] [Related]
7. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
[No Abstract] [Full Text] [Related]
8. Selective cyclooxygenase-2 inhibitors.
Golden BD; Abramson SB
Rheum Dis Clin North Am; 1999 May; 25(2):359-78. PubMed ID: 10356423
[TBL] [Abstract][Full Text] [Related]
9. Cox-2 inhibitors: a new class of medication?
Habershaw TA
Med Health R I; 1999 Sep; 82(9):332-4. PubMed ID: 10517079
[No Abstract] [Full Text] [Related]
10. [Clinical use of COX-2 inhibitors].
Ristić GG; Stefanović DZ
Vojnosanit Pregl; 2001; 58(3):283-95. PubMed ID: 11548555
[No Abstract] [Full Text] [Related]
11. An update on specific COX-2 inhibitors: the COXIBs.
Gupta S; Crofford LJ
Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
[No Abstract] [Full Text] [Related]
12. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
[TBL] [Abstract][Full Text] [Related]
13. [COX-1 and COX-2: functions and pharmacological effects].
Hinz B; Brune K
Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
[No Abstract] [Full Text] [Related]
14. Clinical implications of selective cyclooxygenase-2 inhibition.
Emery P
Scand J Rheumatol Suppl; 1996; 102():23-8. PubMed ID: 8628978
[TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibitors. Magic bullets or merely mortal?
Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
[No Abstract] [Full Text] [Related]
16. Efficacy of cyclooxygenase-2-specific inhibitors.
Cannon GW; Breedveld FC
Am J Med; 2001 Feb; 110 Suppl 3A():6S-12S. PubMed ID: 11173044
[TBL] [Abstract][Full Text] [Related]
17. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
18. COX-2 inhibitors for colorectal cancer.
Elder DJ; Paraskeva C
Nat Med; 1998 Apr; 4(4):392-3. PubMed ID: 9546780
[No Abstract] [Full Text] [Related]
19. Celecoxib: a COX-2 inhibitor.
Andrews SA; Wallace CK; Davis RL
Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
[No Abstract] [Full Text] [Related]
20. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Jüni P; Rutjes AW; Dieppe PA
BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
